NICOTINE.

Chemical Market Reporter, January, 1999

Elan Corporation PLC and Perrigo Company, Allegan, Mich., have received approval from FDA for Elan's sNDA to change the status of its Nicotine Transdermal System patch from prescription to over-the-counter (OTC). In its prescription format, the product was formerly marketed as ProStep by Wyeth-Ayerst Laboratories.

Perrigo will market and distribute the OTC product principally through the store brand market sector.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here